-transparent.png){kind=logo}
The pharmacokinetics of the new cephalosporin Ro-13-9904 were studied in six healthy male volunteers receiving a 500-mg dose as a bolus intravenously. Tissue penetration of the antibiotic was estimated by using a cantharides blister method. The data obtained fitted a two-compartment open model. The mean elimination half-life was about 8 h, which is considerably longer than that of other beta-lactam compounds. The distribution volume was 4.3 liters in the central compartment. Levels of Ro 13-9904 in blister fluid exceeded those in serum after 6.5 h. Approximately 60% of the antibiotic was excreted in the urine.
Related Publications
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
August 1981,
Antimicrobial agents and chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
December 1980,
Antimicrobial agents and chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
March 1981,
Antimicrobial agents and chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
March 1981,
Antimicrobial agents and chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
July 1980,
The Journal of antibiotics,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
September 1980,
The Journal of antimicrobial chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
February 1981,
Antimicrobial agents and chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
January 1981,
Antimicrobial agents and chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
June 1982,
Antimicrobial agents and chemotherapy,
M Seddon, and
R Wise, and
A P Gillett, and
R Livingston
January 1981,
Antimicrobial agents and chemotherapy,
